Interferon Gamma Release Assay for the Identification of Latent Tuberculosis Infection in Rural and Remote Settings: Clinical Utility, Cost-Effectiveness, and Guidelines


( Last Updated : August 17, 2020)
Project Line:
Reference List
Project Sub Line:
Summary of Abstracts
Project Number:
RB1512-000

Details


Question


  1. What is the clinical utility of the interferon gamma release assay for identifying latent tuberculosis infection in rural and remote settings?

  2. What is the cost-effectiveness of the interferon gamma release assay for identifying latent tuberculosis infection in rural and remote settings?

  3. What are the evidence-based guidelines regarding the identification of latent tuberculosis infection in rural and remote settings?


Key Message

One systematic review was identified regarding the clinical utility of the interferon gamma release assay for identifying latent tuberculosis infection in rural and remote settings. No relevant economic evaluations were identified regarding the cost-effectiveness of the interferon gamma release assay for identifying latent tuberculosis infection in rural and remote settings. In addition, no relevant evidence-based guidelines were identified regarding the identification of latent tuberculosis infection in rural and remote settings.